Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 51 - 100 av 182 resultater
Tid
Selskap
Tittel
Sektor
Kategori
04 May 2023
22:01 CEST
GALAPAGOS
Galapagos announces first quarter 2023 financial results
20103010 Biotechnology
Other subject
04 May 2023
22:01 CEST
GALAPAGOS
Galapagos rapporteert financiële resultaten voor het eerste kwartaal van 2023
20103010 Biotechnology
Other subject
02 May 2023
22:01 CEST
GALAPAGOS
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
20103010 Biotechnology
Other subject
02 May 2023
22:01 CEST
GALAPAGOS
Galapagos kondigt vertrek aan van Bart Filius, Chief Operating Officer en Chief Financial Officer
20103010 Biotechnology
Other subject
26 Apr 2023
22:01 CEST
GALAPAGOS
Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis
20103010 Biotechnology
Other subject
26 Apr 2023
22:01 CEST
GALAPAGOS
Galapagos start fase 3-programma met filgotinib bij patiënten met actieve axiale spondyloartritis
20103010 Biotechnology
Other subject
25 Apr 2023
22:01 CEST
GALAPAGOS
Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting
20103010 Biotechnology
Other subject
25 Apr 2023
22:01 CEST
GALAPAGOS
Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse aandeelhoudersvergadering
20103010 Biotechnology
Other subject
30 Mar 2023
22:30 CEST
GALAPAGOS
Galapagos and NovAliX enter into an integrated drug discovery collaboration
20103010 Biotechnology
Other subject
30 Mar 2023
22:30 CEST
GALAPAGOS
Galapagos en NovAliX gaan een geïntegreerde samenwerking aan op het gebied van geneesmiddelenonderzoek
20103010 Biotechnology
Other subject
23 Mar 2023
21:01 CET
GALAPAGOS
Galapagos publiceert jaarverslag 2022 en kondigt Gewone Algemene Vergadering aan
20103010 Biotechnology
Other subject
23 Mar 2023
21:01 CET
GALAPAGOS
Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting
20103010 Biotechnology
Other subject
20 Mar 2023
21:01 CET
GALAPAGOS
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
20103010 Biotechnology
Other subject
20 Mar 2023
21:01 CET
GALAPAGOS
Galapagos increases share capital through subscription right exercises
20103010 Biotechnology
Other subject
27 Feb 2023
22:01 CET
GALAPAGOS
Galapagos presenteert nieuwe data van langetermijn-uitbreidingsstudie van filgotinib bij colitis ulcerosa op jaarlijks ECCO congres 2023
20103010 Biotechnology
Other subject
27 Feb 2023
22:01 CET
GALAPAGOS
Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
20103010 Biotechnology
Other subject
23 Feb 2023
22:01 CET
GALAPAGOS
Galapagos announces full year 2022 results and outlook for 2023
20103010 Biotechnology
Other subject
23 Feb 2023
22:01 CET
GALAPAGOS
Galapagos kondigt 2022 jaarresultaten en vooruitzichten 2023 aan
20103010 Biotechnology
Other subject
09 Feb 2023
22:01 CET
GALAPAGOS
Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL
20103010 Biotechnology
Other subject
09 Feb 2023
22:01 CET
GALAPAGOS
Galapagos heeft bemoedigende eerste gegevens gepresenteerd over veiligheid en werkzaamheid van point-of-care vervaardigde CAR-T kandidaat, GLPG5201, in rrCLL, op EBMT-EHA 2023
20103010 Biotechnology
Other subject
08 Feb 2023
22:01 CET
GALAPAGOS
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
20103010 Biotechnology
Other subject
08 Feb 2023
22:01 CET
GALAPAGOS
Galapagos kondigt topline resultaten aan van fase 3 DIVERSITY-studie met filgotinib bij de ziekte van Crohn
20103010 Biotechnology
Other subject
10 Jan 2023
22:01 CET
GALAPAGOS
Galapagos receives transparency notification from FMR LLC
20103010 Biotechnology
Other subject
10 Jan 2023
22:01 CET
GALAPAGOS
Galapagos ontvangt transparantieverklaring van FMR LLC
20103010 Biotechnology
Other subject
03 Jan 2023
22:01 CET
GALAPAGOS
Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference
20103010 Biotechnology
Other subject
03 Jan 2023
22:01 CET
GALAPAGOS
Galapagos geeft presentatie op 41ste jaarlijkse J.P. Morgan Healthcare Conference
20103010 Biotechnology
Other subject
23 Dec 2022
22:01 CET
GALAPAGOS
Galapagos ontvangt transparantieverklaring van FMR LLC
20103010 Biotechnology
Other subject
23 Dec 2022
22:01 CET
GALAPAGOS
Galapagos receives transparency notification from FMR LLC
20103010 Biotechnology
Other subject
22 Dec 2022
22:01 CET
GALAPAGOS
Galapagos kondigt wijzigingen in Directiecomité aan
20103010 Biotechnology
Other subject
22 Dec 2022
22:01 CET
GALAPAGOS
Galapagos announces changes to Executive Committee
20103010 Biotechnology
Other subject
13 Dec 2022
07:00 CET
GALAPAGOS
Galapagos en CellPoint hebben op ASH 2022 bemoedigende eerste data gepresenteerd van GLPG5101, een CD19 CAR-T-kandidaat die point-of-care wordt geproduceerd
20103010 Biotechnology
Other subject
13 Dec 2022
07:00 CET
GALAPAGOS
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
20103010 Biotechnology
Other subject
11 Nov 2022
13:15 CET
GALAPAGOS
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
20103010 Biotechnology
Other subject
11 Nov 2022
13:15 CET
GALAPAGOS
Galapagos kondigt aan dat het CHMP de aanbeveling van het PRAC voor Jyseleca® heeft overgenomen na een uitgebreide veiligheidsbeoordeling van alle JAK-remmers
20103010 Biotechnology
Other subject
08 Nov 2022
22:01 CET
GALAPAGOS
Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022
20103010 Biotechnology
Other subject
08 Nov 2022
22:01 CET
GALAPAGOS
Galapagos presenteert bemoedigende eerste data van FILOSOPHY-real world studie naar artritis tijdens ACR Convergence 2022
20103010 Biotechnology
Other subject
04 Nov 2022
21:01 CET
GALAPAGOS
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
20103010 Biotechnology
Other subject
04 Nov 2022
21:01 CET
GALAPAGOS
Galapagos presenteert stappenplan voor pijplijn- en commerciële groei op haar R&D-dag 2022
20103010 Biotechnology
Other subject
03 Nov 2022
21:01 CET
GALAPAGOS
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
20103010 Biotechnology
Other subject
03 Nov 2022
21:01 CET
GALAPAGOS
Galapagos kondigt strategie aan om innovatie te versnellen en rapporteert sterke resultaten in derde kwartaal 2022
20103010 Biotechnology
Other subject
17 Oct 2022
07:30 CEST
GALAPAGOS
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
20103010 Biotechnology
Other subject
17 Oct 2022
07:30 CEST
GALAPAGOS
Galapagos organiseert haar R&D Update 2022 in New York op 4 november 2022
20103010 Biotechnology
Other subject
06 Oct 2022
22:01 CEST
GALAPAGOS
Galapagos geeft verdere inzichten in de behandeling van colitis ulcerosa tijdens de komende United European Gastroenterology (UEG) Week 2022
20103010 Biotechnology
Other subject
06 Oct 2022
22:01 CEST
GALAPAGOS
Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
20103010 Biotechnology
Other subject
03 Oct 2022
22:01 CEST
GALAPAGOS
Galapagos ontvangt positief CHMP-advies voor update van het Europees label voor Jyseleca® gebaseerd op testiculaire functie veiligheidsgegevens van MANTA/RAy studies
20103010 Biotechnology
Other subject
03 Oct 2022
22:01 CEST
GALAPAGOS
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
20103010 Biotechnology
Other subject
27 Sep 2022
22:01 CEST
GALAPAGOS
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
20103010 Biotechnology
Other subject
27 Sep 2022
22:01 CEST
GALAPAGOS
Galapagos increases share capital through subscription right exercises
20103010 Biotechnology
Other subject
29 Aug 2022
22:01 CEST
GALAPAGOS
Galapagos receives transparency notification from FMR LLC
20103010 Biotechnology
Other subject
29 Aug 2022
22:01 CEST
GALAPAGOS
Galapagos ontvangt transparantieverklaring van FMR LLC
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva